Cargando…
Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy
The paradigm of drug delivery via particulate formulations is one of the leading ideas that enable overcoming limitations of traditional chemotherapeutic agents. The trend toward more complex multifunctional drug carriers is well-traced in the literature. Nowadays, the prospectiveness of stimuli-res...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222897/ https://www.ncbi.nlm.nih.gov/pubmed/37242807 http://dx.doi.org/10.3390/pharmaceutics15051566 |
_version_ | 1785049810322063360 |
---|---|
author | Verkhovskii, Roman A. Ivanov, Alexey N. Lengert, Ekaterina V. Tulyakova, Ksenia A. Shilyagina, Natalia Yu. Ermakov, Alexey V. |
author_facet | Verkhovskii, Roman A. Ivanov, Alexey N. Lengert, Ekaterina V. Tulyakova, Ksenia A. Shilyagina, Natalia Yu. Ermakov, Alexey V. |
author_sort | Verkhovskii, Roman A. |
collection | PubMed |
description | The paradigm of drug delivery via particulate formulations is one of the leading ideas that enable overcoming limitations of traditional chemotherapeutic agents. The trend toward more complex multifunctional drug carriers is well-traced in the literature. Nowadays, the prospectiveness of stimuli-responsive systems capable of controlled cargo release in the lesion nidus is widely accepted. Both endogenous and exogenous stimuli are employed for this purpose; however, endogenous pH is the most common trigger. Unfortunately, scientists encounter multiple challenges on the way to the implementation of this idea related to the vehicles’ accumulation in off-target tissues, their immunogenicity, the complexity of drug delivery to intracellular targets, and finally, the difficulties in the fabrication of carriers matching all imposed requirements. Here, we discuss fundamental strategies for pH-responsive drug delivery, as well as limitations related to such carriers’ application, and reveal the main problems, weaknesses, and reasons for poor clinical results. Moreover, we attempted to formulate the profiles of an “ideal” drug carrier in the frame of different strategies drawing on the example of metal-comprising materials and considered recently published studies through the lens of these profiles. We believe that this approach will facilitate the formulation of the main challenges facing researchers and the identification of the most promising trends in technology development. |
format | Online Article Text |
id | pubmed-10222897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102228972023-05-28 Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy Verkhovskii, Roman A. Ivanov, Alexey N. Lengert, Ekaterina V. Tulyakova, Ksenia A. Shilyagina, Natalia Yu. Ermakov, Alexey V. Pharmaceutics Review The paradigm of drug delivery via particulate formulations is one of the leading ideas that enable overcoming limitations of traditional chemotherapeutic agents. The trend toward more complex multifunctional drug carriers is well-traced in the literature. Nowadays, the prospectiveness of stimuli-responsive systems capable of controlled cargo release in the lesion nidus is widely accepted. Both endogenous and exogenous stimuli are employed for this purpose; however, endogenous pH is the most common trigger. Unfortunately, scientists encounter multiple challenges on the way to the implementation of this idea related to the vehicles’ accumulation in off-target tissues, their immunogenicity, the complexity of drug delivery to intracellular targets, and finally, the difficulties in the fabrication of carriers matching all imposed requirements. Here, we discuss fundamental strategies for pH-responsive drug delivery, as well as limitations related to such carriers’ application, and reveal the main problems, weaknesses, and reasons for poor clinical results. Moreover, we attempted to formulate the profiles of an “ideal” drug carrier in the frame of different strategies drawing on the example of metal-comprising materials and considered recently published studies through the lens of these profiles. We believe that this approach will facilitate the formulation of the main challenges facing researchers and the identification of the most promising trends in technology development. MDPI 2023-05-22 /pmc/articles/PMC10222897/ /pubmed/37242807 http://dx.doi.org/10.3390/pharmaceutics15051566 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Verkhovskii, Roman A. Ivanov, Alexey N. Lengert, Ekaterina V. Tulyakova, Ksenia A. Shilyagina, Natalia Yu. Ermakov, Alexey V. Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy |
title | Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy |
title_full | Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy |
title_fullStr | Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy |
title_full_unstemmed | Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy |
title_short | Current Principles, Challenges, and New Metrics in pH-Responsive Drug Delivery Systems for Systemic Cancer Therapy |
title_sort | current principles, challenges, and new metrics in ph-responsive drug delivery systems for systemic cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222897/ https://www.ncbi.nlm.nih.gov/pubmed/37242807 http://dx.doi.org/10.3390/pharmaceutics15051566 |
work_keys_str_mv | AT verkhovskiiromana currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy AT ivanovalexeyn currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy AT lengertekaterinav currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy AT tulyakovakseniaa currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy AT shilyaginanataliayu currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy AT ermakovalexeyv currentprincipleschallengesandnewmetricsinphresponsivedrugdeliverysystemsforsystemiccancertherapy |